BioCentury
ARTICLE | Company News

AGY Therapeutics, M's Science deal

July 26, 2004 7:00 AM UTC

M's granted AGY exclusive rights to develop and commercialize AGY-94806 (or SA4503), a small molecule sigma receptor agonist, for certain indications. M's has completed a Phase I trial of the compound...